🚀 VC round data is live in beta, check it out!
Microbot Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Microbot Medical and similar public comparables like Quipt Home Medical, Medika, Stille, Ubcare and more.
Microbot Medical Overview
About Microbot Medical
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot’s LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.
Founded
1988
HQ
Employees
21
Website
Sectors
Financials (LTM)
EV
$86M
Microbot Medical Financials
Microbot Medical reported last 12-month revenue of $1M and negative EBITDA of ($17M).
In the same LTM period, Microbot Medical generated $371K in gross profit, ($17M) in EBITDA losses, and had net loss of ($16M).
Revenue (LTM)
Microbot Medical P&L
In the most recent fiscal year, Microbot Medical reported revenue of $113K and EBITDA of ($15M).
Microbot Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $1M | XXX | $113K | XXX | XXX | XXX |
| Gross Profit | $371K | XXX | — | XXX | XXX | XXX |
| Gross Margin | 33% | XXX | — | XXX | XXX | XXX |
| EBITDA | ($17M) | XXX | ($15M) | XXX | XXX | XXX |
| EBITDA Margin | (1515%) | XXX | (12967%) | XXX | XXX | XXX |
| EBIT Margin | (1552%) | XXX | (13009%) | XXX | XXX | XXX |
| Net Profit | ($16M) | XXX | ($13M) | XXX | XXX | XXX |
| Net Margin | (1435%) | XXX | (11596%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Microbot Medical Stock Performance
Microbot Medical has current market cap of $165M, and enterprise value of $86M.
Market Cap Evolution
Microbot Medical's stock price is $2.46.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $86M | $165M | 0.0% | XXX | XXX | XXX | $-0.20 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMicrobot Medical Valuation Multiples
Microbot Medical trades at 76.8x EV/Revenue multiple, and (5.1x) EV/EBITDA.
EV / Revenue (LTM)
Microbot Medical Financial Valuation Multiples
As of March 28, 2026, Microbot Medical has market cap of $165M and EV of $86M.
Equity research analysts estimate Microbot Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Microbot Medical has a P/E ratio of (10.3x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $165M | XXX | $165M | XXX | XXX | XXX |
| EV (current) | $86M | XXX | $86M | XXX | XXX | XXX |
| EV/Revenue | 76.8x | XXX | 755.4x | XXX | XXX | XXX |
| EV/EBITDA | (5.1x) | XXX | (5.8x) | XXX | XXX | XXX |
| EV/EBIT | (4.9x) | XXX | (5.8x) | XXX | XXX | XXX |
| EV/Gross Profit | 230.5x | XXX | — | XXX | XXX | XXX |
| P/E | (10.3x) | XXX | (12.5x) | XXX | XXX | XXX |
| EV/FCF | (5.4x) | XXX | (6.5x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Microbot Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Microbot Medical Margins & Growth Rates
Microbot Medical's revenue in the last 12 month grew by 397%.
Microbot Medical's revenue per employee in the last FY averaged $0.1M.
Microbot Medical's rule of 40 is (1118%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Microbot Medical's rule of X is (523%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Microbot Medical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 397% | XXX | 3708% | XXX | XXX | XXX |
| EBITDA Margin | (1515%) | XXX | (12967%) | XXX | XXX | XXX |
| EBITDA Growth | 41% | XXX | 63% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | (1118%) | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | (523%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| G&A Expenses to Revenue | 1125% | XXX | 7277% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 527% | XXX | 5544% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 13009% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Microbot Medical Public Comps
See public comps and valuation multiples for other Medical Supplies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Quipt Home Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Medika | XXX | XXX | XXX | XXX | XXX | XXX |
| Stille | XXX | XXX | XXX | XXX | XXX | XXX |
| Ubcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Sopharma Trading | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Microbot Medical M&A Activity
Microbot Medical acquired XXX companies to date.
Last acquisition by Microbot Medical was on XXXXXXXX, XXXXX. Microbot Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Microbot Medical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMicrobot Medical Investment Activity
Microbot Medical invested in XXX companies to date.
Microbot Medical made its latest investment on XXXXXXXX, XXXXX. Microbot Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Microbot Medical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Microbot Medical
| When was Microbot Medical founded? | Microbot Medical was founded in 1988. |
| Where is Microbot Medical headquartered? | Microbot Medical is headquartered in United States. |
| How many employees does Microbot Medical have? | As of today, Microbot Medical has over 21 employees. |
| Who is the CEO of Microbot Medical? | Microbot Medical's CEO is Harel Gadot. |
| Is Microbot Medical publicly listed? | Yes, Microbot Medical is a public company listed on Nasdaq. |
| What is the stock symbol of Microbot Medical? | Microbot Medical trades under MBOT ticker. |
| When did Microbot Medical go public? | Microbot Medical went public in 1992. |
| Who are competitors of Microbot Medical? | Microbot Medical main competitors are Quipt Home Medical, Medika, Stille, Ubcare. |
| What is the current market cap of Microbot Medical? | Microbot Medical's current market cap is $165M. |
| What is the current revenue of Microbot Medical? | Microbot Medical's last 12 months revenue is $1M. |
| What is the current revenue growth of Microbot Medical? | Microbot Medical revenue growth (NTM/LTM) is 397%. |
| What is the current EV/Revenue multiple of Microbot Medical? | Current revenue multiple of Microbot Medical is 76.8x. |
| Is Microbot Medical profitable? | No, Microbot Medical is not profitable. |
| What is the current EBITDA of Microbot Medical? | Microbot Medical has negative EBITDA and is not profitable. |
| What is Microbot Medical's EBITDA margin? | Microbot Medical's last 12 months EBITDA margin is (1515%). |
| What is the current EV/EBITDA multiple of Microbot Medical? | Current EBITDA multiple of Microbot Medical is (5.1x). |
| What is the current FCF of Microbot Medical? | Microbot Medical's last 12 months FCF is ($16M). |
| What is Microbot Medical's FCF margin? | Microbot Medical's last 12 months FCF margin is (1430%). |
| What is the current EV/FCF multiple of Microbot Medical? | Current FCF multiple of Microbot Medical is (5.4x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.